The study aimed to estimate  the role of glucagon-like peptide-1 (GLP-1)  and visfatin as a novel  pro inflammatory marker in Rheumatoid Arthritis (RA ) according to the activity scores of disease to assess the possibility of introducing glucagon-like peptide-1 and visfatin in the diagnosis and monitoring of RA patients and to found the correlation  of visfatin level with GLP-1 and AIP in patients prone to atherosclerosis ,fifty  healthy individuals as control group (G1) and fifty rheumatoid arthritis (RA) patients (G2) were enrolled in this study with middle age  ranged (30 – 40) years and BMI ≥24 kg/m2. ESR ,RF, lipid profile, CRP,insulin, visfatin and GLP-1were determined. Results in table (1) revealed highly significant increase in ESR,RF,TC,TG,LDL,VLDL and AIP level in rheumatoid arthritis (G2) comparing  to (G1) while significant decrease noticed in (G2) group comparing  to (G1). Results in table(2) showed highly significant increase in insulin ,CRP, visfatin and GLP-1 level   Results in table(3) illustrated correlation relation data and results revealed highly significant ,were r=0.035 for GLP-1 with visfatin for (G1), and highly significant , r= -0.089 for (G2)  as shown in figure(1-A) and(1-B),  the result also highly significant were r= -0.183 for  GLP-1 with CRP for control group and significant ,r= 0.043 for GLP-1 with CRP  for RA group as shown in figure(2-A) and(2-B), and  significant, r= -0.056 for GLP-1with AIP  for G1 and no significant, were r= 0.042 for GLP-1 with AIP  for G2  as  shown in figure (3-A)and (3-B). conclusion that summarized from this study is glucagon-like peptide-1 and  visfatin plays a role in RA pathogenesis that can be considered marker in RA . and may be used as a drug in future for  RA patients.